65-Terbium-161. National Nuclear Data Centre. (2011).https://www.nndc.bnl.gov/mird/.
Abuqbeitah M, Demir M, Çavdar İ, Tanyildizi H, Yeyin N, Uslu-Beşli L, Kabasakal L, Işıkcı Nİ, Sönmezoğlu K. Red bone marrow dose estimation using several internal dosimetry models for prospective dosimetry-oriented radioiodine therapy. Radiat Environ Biophys. 2018;57(4):395–404.
Article
CAS
PubMed
Google Scholar
Aghevlian S, Lu Y, Winnik MA, Hedley DW, Reilly RM. Panitumumab modified with metal-chelating polymers (MCP) complexed to 111In and 177Lu—an EGFR-targeted theranostic for pancreatic cancer. Mol Pharm. 2018;15(3):1150–9.
Article
CAS
PubMed
Google Scholar
Andersson M, Johansson L, Eckerman K, Mattsson S. IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms. EJNMMI Res. 2017;7(1):88.
Article
PubMed
PubMed Central
CAS
Google Scholar
Areberg J, Björkman S, Einarsson L, Frankenberg B, Lundqvist H, Mattsson S, Norrgren K, Scheike O, Wallin R. Gamma camera imaging of platinum in tumours and tissues of patients after administration of 191Pt-cisplatin. Acta Oncol. 1999;38(2):221–8.
Article
CAS
PubMed
Google Scholar
Areberg J, Johnsson A, Wennerberg J. In vitro toxicity of 191Pt-labeled cisplatin to a human cervical carcinoma cell line (ME-180). Int J Radiat Oncol Biol Phys. 2000;46(5):1275–80.
Article
CAS
PubMed
Google Scholar
Areberg J, Wennerberg J, Johnsson A, Norrgren K, Mattsson S. Antitumor effect of radioactive cisplatin (191Pt) on nude mice. Int J Radiat Oncol Biol Phys. 2001;49(3):827–32.
Article
CAS
PubMed
Google Scholar
Auger P. Sur les rayons β secondaires produits dans un gaz par des rayons X. CR Acad Sci. 1923;177:169.
CAS
Google Scholar
Auger P. L’effet photoélectrique compose. Ann Phys. 1926;10(6):183–253.
Article
Google Scholar
Auger P. The Auger effect. Surf Sci. 1975;48(1):1–8.
Article
CAS
Google Scholar
Balagurumoorthy P, Xu X, Wang K, Adelstein SJ, Kassis AI. Effect of distance between decaying 125I and DNA on Auger-electron induced double-strand break yield. Int J of Radiat Biol. 2012;88(12):998–1008.
Article
CAS
Google Scholar
Bavelaar BM, Lee BQ, Gill MR, Falzone N, Vallis KA. Subcellular targeting of theranostic radionuclides. Front Pharmacol. 2018;9.
Beckmann MW, Scharl A, Rosinsky BJ, Holt JA. Breaks in DNA accompany estrogen-receptor-mediated cytotoxicity from 16α [125I] iodo-17β-estradiol. J of Cancer Res Clin Oncol. 1993;119(4):207–14.
Article
CAS
Google Scholar
Behr TM, Béhé M, Löhr M, Sgouros G, Angerstein C, Wehrmann E, Nebendahl K, Becker W. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies. Eur J Nucl Med. 2000;27(7):753–65.
Article
CAS
PubMed
Google Scholar
Berger MJ, Coursey JS, Zucker MA, Chang J. ESTAR, PSTAR, and ASTAR: computer programs for calculating stopping-power and range tables for electrons, protons, and helium ions (version 1.2.3). Natl Inst Stand Technol. 2005; http://physics.nist.gov/Star.
Bergstrom D, Leyton JV, Zereshkian A, Chan C, Cai Z, Reilly RM. Paradoxical effects of Auger electron-emitting 111In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45+ cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice. Nucl Med Biol. 2016;43(10):635–41.
Article
CAS
PubMed
Google Scholar
Bhattathiri NV, Bindu L, Remani P, Chandralekha B, Nair KM. Radiation-induced acute immediate nuclear abnormalities in oral cancer cells: serial cytologic evaluation. Acta Cytol. 1998;42(5):1084–90.
Article
CAS
PubMed
Google Scholar
Bodnar EN, Dikiy MP, Medvedeva EP. Photonuclear production and antitumor effect of radioactive cisplatin (195mPt). J Radioanal Nucl Chem. 2015;305(1):133–8.
Article
CAS
Google Scholar
Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, Erdi AK, Aydogan B, Costes S, Watson EE. MIRD committee. MIRD pamphlet no. 17: the dosimetry of nonuniform activity distributions—radionuclide S values at the voxel level. J Nucl Med. 1999;40(1):11S–36S.
CAS
PubMed
Google Scholar
Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature. J Nucl Med. 2009;50(3):477–84.
Article
CAS
PubMed
Google Scholar
Bonnet D, Bhatia M, Wang JC, Kapp U, Dick JE. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant. 1999;23(3):203.
Article
CAS
PubMed
Google Scholar
Bouchet LG, Bolch WE, Blanco HP, Wessels BW, Siegel JA, Rajon DA, Clairand I, Sgouros G. MIRD pamphlet no. 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney. J Nucl Med. 2003;44(7):1113–47.
PubMed
Google Scholar
Bouchet LG, Bolch WE, Weber DA, Atkins HL, Poston JW. MIRD pamphlet no. 15: radionuclide S values in a revised dosimetric model of the adult head and brain. J Nucl Med. 1999;40:62S–71S.
CAS
PubMed
Google Scholar
Boyd M, Ross SC, Dorrens J, Fullerton NE, Tan KW, Zalutsky MR, Mairs RJ. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with α-, β-, and Auger electron–emitting radionuclides. J Nucl Med. 2006;47(6):1007–15.
CAS
PubMed
Google Scholar
Brom M, Joosten L, Oyen WJ, Gotthardt M, Boerman OC. Improved labelling of DTPA-and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer. EJNMMI Res. 2012;2(1):4.
Article
PubMed
PubMed Central
CAS
Google Scholar
Burdak-Rothkamm S, Prise KM. New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells. Eur J Pharmacol. 2009;625(1–3):151–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cai Z, Chattopadhyay N, Yang K, Kwon YL, Yook S, Pignol JP, Reilly RM. 111In-labeled trastuzumab-modified gold nanoparticles are cytotoxic in vitro to HER2-positive breast cancer cells and arrest tumor growth in vivo in athymic mice after intratumoral injection. Nucl Med Biol. 2016;43(12):818–26.
Article
CAS
PubMed
Google Scholar
Cai Z, Chen Z, Bailey KE, Scollard DA, Reilly RM, Vallis KA. Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF. J Nucl Med. 2008;49(8):1353–61.
Article
CAS
PubMed
Google Scholar
Cai Z, Kwon YL, Reilly RM. Monte Carlo N-particle (MCNP) modeling of the cellular dosimetry of 64Cu: comparison with MIRDcell S values and implications for studies of its cytotoxic effects. J Nucl Med. 2017;58(2):339–45.
Article
CAS
PubMed
Google Scholar
Cai Z, Pignol JP, Chan C, Reilly RM. Cellular dosimetry of in-111 using Monte Carlo N-particle computer code: comparison with analytic methods and correlation with in vitro cytotoxicity. J Nucl Med. 2010;51:462–70.
Article
PubMed
Google Scholar
Cai Z, Vallis KA, Reilly RM. Computational analysis of the number, area and density of γ-H2AX foci in breast cancer cells exposed to 111In-DTPA-hEGF or γ-rays using image-J software. Int J Radiat Biol. 2009;85(3):262–71.
Article
CAS
PubMed
Google Scholar
Capello A, Krenning E, Bernard B, Reubi JC, Breeman W, de Jong M. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy. Eur J Nucl Med Mol Imaging. 2005;32(11):1288–95.
Article
CAS
PubMed
Google Scholar
Capello A, Krenning EP, Breeman WA, Bernard BF, de Jong M. Peptide receptor radionuclide therapy in vitro using [111In-DTPA0] octreotide. J Nucl Med. 2003;44(1):98–104.
CAS
PubMed
Google Scholar
Carr BI. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl. 2004;10(S2):S107–10.
Article
PubMed
Google Scholar
Carrillo-Cázares TA, Torres-García E. Monte Carlo mitochondrial dosimetry and microdosimetry of 131I. Radiat Prot Dosim. 2012;153(4):411–6.
Article
CAS
Google Scholar
Chalkia MT, Stefanoyiannis AP, Chatziioannou SN, Round WH, Efstathopoulos EP, Nikiforidis GC. Patient-specific dosimetry in peptide receptor radionuclide therapy: a clinical review. Australas Phys Eng Sci Med. 2015;38(1):7–22.
Article
CAS
PubMed
Google Scholar
Chan C, Cai Z, Reilly RM. Trastuzumab labeled to high specific activity with 111In by conjugation to G4 PAMAM dendrimers derivatized with multiple DTPA chelators exhibits increased cytotoxic potency on HER2-positive breast cancer cells. Pharm Res. 2013;30(8):1999–2009.
Article
CAS
PubMed
Google Scholar
Chan PC, Lisco E, Lisco H, Adelstein SJ. The radiotoxicity of Iodine-125 in mammalian cells: II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131IUdR, and 3HTdR. J Radiat Res. 1976;67:332–43.
Article
CAS
Google Scholar
Charlton DE. The range of high LET effects from 125I decays. J Radiat Res. 1986;107(2):163–71.
Article
CAS
Google Scholar
Chattopadhyay N, Fonge H, Cai Z, Scollard D, Lechtman E, Done SJ, Pignol JP, Reilly RM. Role of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivo. Mol Pharm. 2012;9(8):2168–79.
Article
CAS
PubMed
Google Scholar
Chen P, Cameron R, Wang J, Vallis KA, Reilly RM. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. J Nucl Med. 2003;44(9):1469–78.
CAS
PubMed
Google Scholar
Chen P, Wang J, Hope K, Jin L, Dick J, Cameron R, Brandwein J, Minden M, Reilly RM. Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. J Nucl Med. 2006;47(5):827–36.
CAS
PubMed
Google Scholar
Chen QQ, Chen XY, Jiang YY, Jing LI. Identification of novel nuclear localization signal within the ErbB-2 protein. Cell Res. 2005;15(7):504.
Article
CAS
PubMed
Google Scholar
Chen Y, Vastenhouw B, Wu C, Goorden MC, Beekman FJ. Optimized image acquisition for dopamine transporter imaging with ultra-high resolution clinical pinhole SPECT. Phys Med Biol. 2018;63(22).
Article
Google Scholar
Chin BB, Kronauge JF, Femia FJ, Chen J, Maresca KP, Hillier S, Petry NA, James OG, Oldan JD, Armor T, Stubbs JB. Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane. J Nucl Med. 2014;55(5):765–71.
Article
CAS
PubMed
Google Scholar
Choppin G, Liljenzin JO, Rydberg J. Chapter 4 - unstable nuclei and radioactive decay. In: Choppin G, Liljenzin JO, Rydberg J, editors. Radiochemistry and nuclear chemistry. 3rd ed. Woburn: Butterworth-Heinemann; 2002. p. 58–93.
Chapter
Google Scholar
Costantini DL, Bateman K, McLarty K, Vallis KA, Reilly RM. Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron–emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate. J Nucl Med. 2008a;49(9):1498–505.
Article
CAS
PubMed
Google Scholar
Costantini DL, Chan C, Cai Z, Vallis KA, Reilly RM. 111In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer. J Nucl Med. 2007;48(8):1357–68.
Article
CAS
PubMed
Google Scholar
Costantini DL, Hu M, Reilly RM. Update: peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications. Cancer Biother Radiopharm. 2008b;23(1):3–24.
Article
CAS
PubMed
Google Scholar
Costantini DL, McLarty K, Lee H, Done SJ, Vallis KA, Reilly RM. Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenografts. J Nucl Med. 2010;51(7):1084–91.
Article
CAS
PubMed
Google Scholar
Desbois N, Gardette M, Papon J, Labarre P, Maisonial A, Auzeloux P, Lartigue C, Bouchon B, Debiton E, Blache Y, Chavignon O. Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma. Bioorg Med Chem. 2008;16(16):7671–90.
Article
CAS
PubMed
Google Scholar
Dewaraja YK, Frey EC, Sgouros G, Brill AB, Roberson P, Zanzonico PB, Ljungberg M. MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J Nucl Med. 2012;53(8):1310–25.
Article
CAS
PubMed
Google Scholar
Di Maria S, Belchior A, Romanets Y, Paulo A, Vaz P. Monte Carlo dose distribution calculation at nuclear level for Auger-emitting radionuclide energies. Appl Radiat Isot. 2018;135:72–7.
Article
PubMed
CAS
Google Scholar
Dong Y, Gao Y, Liu W, Gao T, Zheng Y, Sanche L. Clustered DNA damage induced by 2–20 eV electrons and transient anions: general mechanism and correlation to cell death. J Phys Chem Lett. 2019;10(11):2985–90.
Article
CAS
PubMed
Google Scholar
Dykiy MP, Dovbnya AN, Lyashko YV, Medvedeva EP, Medvedev DV, Uvarov VL. Photonuclear production of 193m, 195mPt and synthesis of radioactive cisplatin. J Labelled Comp Radiopharm. 2007;50:480–2.
Article
CAS
Google Scholar
Eckerman KF, Endo A. MIRD: Radionuclide Data and Decay Schemes. 2nd ed. Reston, VA: Society of Nuclear Medicine; 2008. p. 117.
Google Scholar
Elmroth K, Stenerlöw B. DNA-incorporated 125I induces more than one double-strand break per decay in mammalian cells. J Radiat Res. 2005;163(4):369–73.
Article
CAS
Google Scholar
Eriksson D, Stigbrand T. Radiation-induced cell death mechanisms. Tumor Biol. 2010;31(4):363–72.
Article
Google Scholar
Falzone N, Ackerman NL, de la Fuente RL, Bernal MA, Liu X, Peeters SG, Soto MS, Corroyer-Dulmont A, Bernaudin M, Grimoin E, Touzani O. Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases. Theranostics. 2018;8(1):292.
Article
CAS
PubMed
PubMed Central
Google Scholar
Falzone N, Lee BQ, Able S, Malcolm J, Terry S, Alayed Y, Vallis KA. Targeting micrometastases: the effect of heterogeneous radionuclide distribution on tumor control probability. J Nucl Med. 2019;60(2):250–8.
Article
CAS
PubMed Central
Google Scholar
Falzone N, Lee BQ, Fernández-Varea JM, Kartsonaki C, Stuchbery AE, Kibédi T, Vallis KA. Absorbed dose evaluation of Auger electron-emitting radionuclides: impact of input decay spectra on dose point kernels and S-values. Phys Med Biol. 2017;62(6):2239.
Article
CAS
PubMed
Google Scholar
Faraggi M, Gardin I, de Labriolle-Vaylet C, Moretti JL, Bok BD. The influence of tracer localization on the electron dose rate delivered to the cell nucleus. J Nucl Med. 1994;35(1):113–9.
CAS
PubMed
Google Scholar
Fasih A, Fonge H, Cai Z, Leyton JV, Tikhomirov I, Done SJ, Reilly RM. 111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer. Breast Cancer Res Treat. 2012;135(1):189–200.
Article
CAS
PubMed
Google Scholar
Fisher DR, Shen S, Meredith RF. MIRD dose estimate report no. 20: radiation absorbed-dose estimates for 111In-and 90Y-ibritumomab tiuxetan. J Nucl Med. 2009;50(4):644–52.
Article
CAS
PubMed
Google Scholar
Fonge H, Lee H, Reilly RM, Allen C. Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy. Mol Pharm. 2009;7(1):177–86.
Article
CAS
Google Scholar
Fraker PJ, Speck JC Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem Biophys Res Commun. 1978;80(4):849–57.
Article
CAS
PubMed
Google Scholar
Freudenberg R, Runge R, Maucksch U, Berger V, Kotzerke J. On the dose calculation at the cellular level and its implications for the RBE of 99mTc and 123I. Med Phys. 2014;41(6Part1):062503.
Article
CAS
PubMed
Google Scholar
Gallardo A, Lerma E, Escuin D, Tibau A, Munoz J, Ojeda B, Barnadas A, Adrover E, Sánchez-Tejada L, Giner D, Ortiz-Martínez F. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. Br J Cancer. 2012;106(8):1367.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gao C, Leyton JV, Schimmer AD, Minden M, Reilly RM. Auger electron-emitting 111In-DTPA-NLS-CSL360 radioimmunoconjugates are cytotoxic to human acute myeloid leukemia (AML) cells displaying the CD123+/CD131− phenotype of leukemia stem cells. Int J Rad Appl Instrum A. 2016;110:1–7.
CAS
Google Scholar
Gardette M, Viallard C, Paillas S, Guerquin-Kern JL, Papon J, Moins N, Labarre P, Desbois N, Wong-Wah-Chung P, Palle S, Wu TD. Evaluation of two 125I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma. Investig New Drugs. 2014;32(4):587–97.
Article
CAS
Google Scholar
Ghosh A, Heston WD. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem. 2004;91(3):528–39.
Article
CAS
PubMed
Google Scholar
Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao D. MIRD Cellular S Values. Reston, VA: Society of Nuclear Medicine; 1997.
Google Scholar
Goddu SM, Narra VR, Harapanhalli RS, Howell RW, Rao DV. Radioprotection by DMSO against the biological effects of incorporated radionuclides in vivo: comparison with other radioprotectors and evidence for indirect action of Auger electrons. Acta Oncol. 1996;35(7):901–7.
Article
CAS
PubMed
Google Scholar
Gorodetsky R, Levy-Agababa F, Mou X, Vexler AM. Combination of cisplatin and radiation in cell culture: effect of duration of exposure to drug and timing of irradiation. Int J Cancer. 1998;75(4):635–42.
Article
CAS
PubMed
Google Scholar
Haefliger P, Agorastos N, Renard A, Giambonini-Brugnoli G, Marty C, Alberto R. Cell uptake and radiotoxicity studies of an nuclear localization signal peptide− intercalator conjugate labeled with [99mTc (CO)3]+. Bioconjug Chem. 2005;16(3):582–7.
Article
CAS
PubMed
Google Scholar
Haines GA, Hendry JH, Daniel CP, Morris ID. Increased levels of comet-detected spermatozoa DNA damage following in vivo isotopic-or X-irradiation of spermatogonia. Mutat Res Genet Toxicol Environ Mutagen. 2001;495(1–2):21–32.
Article
CAS
Google Scholar
Hoang B, Ekdawi SN, Reilly RM, Allen C. Active targeting of block copolymer micelles with trastuzumab fab fragments and nuclear localization signal leads to increased tumor uptake and nuclear localization in HER2-overexpressing xenografts. Mol Pharm. 2013;10(11):4229–41.
Article
CAS
PubMed
Google Scholar
Hoang B, Reilly RM, Allen C. Block copolymer micelles target auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells. Biomacromolecules. 2012;13(2):455–65.
Article
CAS
PubMed
Google Scholar
Howell RW. Radiation spectra for Auger electron emitting radionuclides: report no. 2 of AAPM nuclear medicine task group no. 6. Med Phys. 1992;19(6):1371–83.
Article
CAS
PubMed
Google Scholar
Hoyes KP, Lord BI, McCann C, Hendry JH, Morris ID. Transgenerational effects of preconception paternal contamination with 55Fe. Radiat Res. 2001;156(5):488–94.
Article
CAS
PubMed
Google Scholar
Hubbell JH, Seltzer SM. Tables of X-ray mass attenuation coefficients and mass energy-absorption coefficients (version 1.4). Natl Inst Stand Technol. 2004; http://physics.nist.gov/xaamdi.
IAEA Radiotracer Biodistribution Template (RaBiT) (n.d.). Available at: https://humanhealth.iaea.org/HHW/MedicalPhysics/NuclearMedicine/InternalDosimetry/iaeaBioDistributionTemplate/.
Ickenstein LM, Edwards K, Sjöberg S, Carlsson J, Gedda L. A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy. Nucl Med Biol. 2006;33(6):773–83.
Article
CAS
PubMed
Google Scholar
IDAC-Dose2.1 (n.d.). Avalable at: http://www.idac-dose.org/.
Iliakis GE, Cicilioni O, Metzger L. Measurement of DNA double-strand breaks in CHO cells at various stages of the cell cycle using pulsed field gel electrophoresis: calibration by means of 125I decay. Int J Radiat Biol. 1991;59(2):343–57.
Article
CAS
PubMed
Google Scholar
Imstepf S, Pierroz V, Raposinho P, Bauwens M, Felber M, Fox T, Shapiro AB, Freudenberg R, Fernandes C, Gama S, Gasser G. Nuclear targeting with an Auger electron emitter potentiates the action of a widely used antineoplastic drug. Bioconjug Chem. 2015;26(12):2397–407.
Article
CAS
PubMed
Google Scholar
Intemann RL, Pollock F. K-electron ejection accompanying nuclear K capture. Phys Rev. 1967;157(1):41.
Article
CAS
Google Scholar
Ismail IH, Nyström S, Nygren J, Hammarsten O. Activation of ataxia telangiectasia mutated by DNA strand break-inducing agents correlates closely with the number of DNA double strand breaks. J Biol Chem. 2005;280(6):4649–55.
Article
CAS
PubMed
Google Scholar
Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, Luger SM. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia. 2000;14(10):1777.
Article
CAS
PubMed
Google Scholar
Karamychev VN, Reed MW, Neumann RD, Panyutin IG. Distribution of DNA strand breaks produced by iodine-123 and indium-111 in synthetic oligodeoxynucleotides. Acta Oncol. 2000;39(6):687–92.
Article
CAS
PubMed
Google Scholar
Kassis AI, Fayad F, Kinsey BM, Sastry KS, Taube RA, Adelstein SJ. Radiotoxicity of 125I in mammalian cells. Radiat Res. 1987;111(2):305–18.
Article
CAS
PubMed
Google Scholar
Kersemans V, Cornelissen B, Minden MD, Brandwein J, Reilly RM. Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences. J Nucl Med. 2008;49(9):1546–54.
Article
CAS
PubMed
Google Scholar
Kesner AL, Bodei L. Modern radiopharmaceutical dosimetry should include robust biodistribution reporting. J Nucl Med. 2018;59(10):1507.
Article
PubMed
Google Scholar
Kesner AL, Poli GL, Beykan S, Lassmann M. The IAEA radiotracer biodistribution template–a community resource for supporting the standardization and reporting of radionuclide pre-dosimetry data. Phys Medica. 2017;44:83–5.
Article
Google Scholar
Kirkby C, Ghasroddashti E. Targeting mitochondria in cancer cells using gold nanoparticle enhanced radiotherapy: a Monte Carlo study. Med Phys. 2015;42(2):1119–28.
Article
CAS
PubMed
Google Scholar
Kirschner AS, Ice RD, Beierwaltes WH. Radiation-dosimetry of 131I-19-iodocholesterol - pitfalls of using tissue concentration data - reply. J Nucl Med. 1975;16:248–9.
CAS
Google Scholar
Konijnenberg MW, Bijster M, Krenning EP, De Jong M. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with 90Y, 111In, or 177Lu. J Nucl Med. 2004;45(7):1260–9.
CAS
PubMed
Google Scholar
Krenning EP, De Jong M, Kooij PP, Breeman WA, Bakker WH, De Herder WW, Van Eijck CH, Kwekkeboom DJ, Jamar F, Pauwels S, Valkema R. Radiolabelled somatostatin analogue (s) for peptide receptor scintigraphy and radionuclide therapy. Ann Oncol. 1999;10(Suppl 2):S23–9.
Article
PubMed
Google Scholar
Kriehuber R, Kadenbach K, Schultz F, Weiss DG. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter 99mTc. Int J Radiat Biol. 2004a;80(11–12):875–80.
Article
CAS
PubMed
Google Scholar
Kriehuber R, Riedling M, Simkó M, Weiss DG. Cytotoxicity, genotoxicity and intracellular distribution of the Auger electron emitter 65Zn in two human cell lines. Radiat Environ Biophys. 2004b;43(1):15–22.
Article
PubMed
Google Scholar
Kwon LY, Scollard DA, Reilly RM. 64Cu-labeled trastuzumab fab-PEG24-EGF radioimmunoconjugates bispecific for HER2 and EGFR: pharmacokinetics, biodistribution, and tumor imaging by PET in comparison to monospecific agents. Mol Pharm. 2017;14(2):492–501.
Article
CAS
PubMed
Google Scholar
Lai P, Cai Z, Pignol JP, Lechtman E, Mashouf S, Lu Y, Winnik MA, Jaffray DA, Reilly RM. Monte Carlo simulation of radiation transport and dose deposition from locally released gold nanoparticles labeled with 111In, 177Lu or 90Y incorporated into tissue implantable depots. Phys Med Biol. 2017;62(22):8581–99.
Article
CAS
PubMed
Google Scholar
Larionov AA. Current therapies for human epidermal growth factor receptor 2-positive metastatic breast cancer patients. Front Oncol. 2018;8:89.
Article
PubMed
PubMed Central
Google Scholar
Lee H, Hoang B, Fonge H, Reilly RM, Allen C. In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels. Pharm Res. 2010;27(11):2343–55.
Article
CAS
PubMed
Google Scholar
Lever JR, Fergason-Cantrell EA, Carmack TL, Watkinson LD, Gallazzi F. Design, synthesis and evaluation of [111In]-labeled, DOTA-conjugated tetrapeptides having high affinity and selectivity for mu opioid receptors. Nucl Med Biol. 2019;70:53–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Leyton JV, Hu M, Gao C, Turner PV, Dick JE, Minden M, Reilly RM. Auger electron radioimmunotherapeutic agent specific for the CD123+/CD131− phenotype of the leukemia stem cell population. J Nucl Med. 2011;52(9):1465–73.
Article
CAS
PubMed
Google Scholar
Leyton JV, Williams B, Gao C, Keating A, Minden M, Reilly RM. MicroSPECT/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+/CD131− epitope expressed by leukemia stem cells. Leuk Res. 2014;38(11):1367–73.
Article
CAS
PubMed
Google Scholar
Li L, Quang TS, Gracely EJ, Kim JH, Emrich JG, Yaeger TE, Jenrette JM, Cohen SC, Black P, Brady LW. A phase II study of anti–epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. J Neurosurg. 2010;113(2):192–8.
Article
PubMed
Google Scholar
Limouris GS, Chatziioannou A, Kontogeorgakos D, Mourikis D, Lyra M, Dimitriou P, Stavraka A, Gouliamos A, Vlahos L. Selective hepatic arterial infusion of in-111-DTPA-Phe1-octreotide in neuroendocrine liver metastases. Eur J Nucl Med Mol Imaging. 2008;35(10):1827–37.
Article
CAS
PubMed
Google Scholar
Lobachevsky PN, White J, Leung M, Skene C, White J, Martin RF. Plasmid breakage by 125I-labelled DNA ligands: effect of DNA-iodine atom distance on breakage efficiency. Int J Radiat Biol. 2008;84(12):991–1000.
Article
CAS
PubMed
Google Scholar
Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations. New York: Society of Nuclear Medicine; 1988.
Google Scholar
López-Coello LI, Torres-García E, Díaz-Sánchez LE, Oros-Pantoja R, Aranda-Lara L. Differences in the S value between male and female murine model for diagnostic, therapeutic and theragnostic radionuclides. Int J Rad Appl Instrum A. 2019;146:61–5.
Google Scholar
Ma J, Kumar A, Muroya Y, Yamashita S, Sakurai T, Denisov SA, Sevilla MD, Adhikary A, Seki S, Mostafavi M. Observation of dissociative quasi-free electron attachment to nucleoside via excited anion radical in solution. Nat Commun. 2019;10(1):102.
Article
PubMed
PubMed Central
CAS
Google Scholar
Macapinlac HA, Kemeny N, Daghighian F, Finn R, Zhang J, Humm J, Squire O, Larson SM. Pilot clinical trial of 5-[125I] iodo-2′-deoxyuridine in the treatment of colorectal cancer metastatic to the liver. J Nucl Med. 1996;37(4 Suppl):25S–9S.
CAS
PubMed
Google Scholar
Mah LJ, Orlowski C, Ververis K, El-Osta AC, Karagiannis T. Utility of γH2AX as a molecular marker of DNA double-strand breaks in nuclear medicine: applications to radionuclide therapy employing auger electron-emitting isotopes. Curr Radiopharm. 2011;4(1):59–67.
Article
CAS
PubMed
Google Scholar
Makrigiorgos GM, Kassis AI, Baranowska-Kortylewicz J, McElvany KD, Welch MJ, Sastry KS, Adelstein SJ. Radiotoxicity of 5-[123I] iodo-2′-deoxyuridine in V79 cells: a comparison with 5-[125I] iodo-2′-deoxyuridine. Radiat Res. 1989;118(3):532–44.
Article
CAS
PubMed
Google Scholar
Marín A, Martín M, Liñán O, Alvarenga F, López M, Fernández L, Büchser D, Cerezo L. Bystander effects and radiotherapy. Rep Pract Oncol Radiother. 2015;20(1):12–21.
Article
PubMed
Google Scholar
Massari R, D’Elia A, Soluri A. A new high-resolution imaging system (HiRIS2) detector for preclinical SPECT imaging. Nucl Instrum Methods Phys Res A. 2019;917:25–30.
Article
CAS
Google Scholar
Mattsson S, Johansson L, Leide SS, Liniecki J, Noßke D, Riklund KÅ, Stabin M, Taylor D, Bolch W, Carlsson S, Eckerman K. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. Ann ICRP. 2015;44(Suppl. 2):7–321.
Article
CAS
PubMed
Google Scholar
McGuire E. Auger and Coster Kronig Transitions. In: Crasemann B, editor. Atomic Inner-Shell Processes. I Ionization and Transition Probabilities. New York: Academic Press; 1975. p. 294.
Google Scholar
Meitner L. Über die Entstehung der β-Strahl-Spektren radioaktiver Substanzen. Z Physik. 1922;9(1):131–44.
Article
CAS
Google Scholar
Michel RB, Brechbiel MW, Mattes MJ. A comparison of 4 radionuclides conjugated to antibodies for single-cell kill. J Nucl Med. 2003;44(4):632–40.
CAS
PubMed
Google Scholar
Michel RB, Castillo ME, Andrews PM, Mattes MJ. In vitro toxicity of A-431 carcinoma cells with antibodies to epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to radionuclides emitting low-energy electrons. Clin Cancer Res. 2004;10(17):5957–66.
Article
CAS
PubMed
Google Scholar
Michel RB, Rosario AV, Andrews PM, Goldenberg DM, Mattes MJ. Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons. Clin Cancer Res. 2005;11(2):777–86.
CAS
PubMed
Google Scholar
MIRDcell, a Multicellular Dosimetry Tool (n.d.). Available at: http://mirdcell.njms.rutgers.edu/mirdcell_v2.1.
Mothersill C, Rusin A, Fernandez-Palomo C, Seymour C. History of bystander effects research 1905-present; what is in a name? Int J Radiat Biol. 2018;94(8):696–707.
Article
CAS
PubMed
Google Scholar
Müller C, Umbricht CA, Gracheva N, Tschan VJ, Pellegrini G, Bernhardt P, Zeevaart JR, Köster U, Schibli R, van der Meulen NP. Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer. Eur J Nucl Med Mol Imaging. 2019:1–2.
Narra VR, Harapanhalli RS, Goddu SM, Howell RW, Rao DV. Radioprotection against biological effects of internal radionuclides in vivo by S-(2-aminoethyl) isothiouronium bromide hydrobromide (AET). J Nucl Med. 1995;36(2):259–66.
CAS
PubMed
Google Scholar
Ngo Ndjock Mbong G, Lu Y, Chan C, Cai Z, Liu P, Boyle AJ, Winnik MA, Reilly RM. Trastuzumab labeled to high specific activity with 111In by site-specific conjugation to a metal-chelating polymer exhibits amplified Auger electron-mediated cytotoxicity on HER2-positive breast cancer cells. Mol Pharm. 2015;12(6):1951–60.
Article
CAS
PubMed
Google Scholar
Ocampo-García BE, Santos-Cuevas CL, Luna-Gutiérrez MA, Ignacio-Alvarez E, Pedraza-López M, Manzano-Mayoral C. 99mTc-exendin (9-39)/octreotide: biokinetics and radiation dosimetry in healthy individuals. Nucl Med Commun. 2017;38(11):912–8.
Article
PubMed
CAS
Google Scholar
Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000;19(13):3159–67.
Article
CAS
PubMed
PubMed Central
Google Scholar
Olive PL, Banath JP. Detection of DNA double-strand breaks through the cell cycle after exposure to X-rays, bleomycin, etoposide and 125IdUrd. Int J Radiat Biol. 1993;64(4):349–58.
Article
CAS
PubMed
Google Scholar
Paillas S, Ladjohounlou R, Lozza C, Pichard A, Boudousq V, Jarlier M, Sevestre S, Le Blay M, Deshayes E, Sosabowski J, Chardes T. Localized irradiation of cell membrane by auger electrons is cytotoxic through oxidative stress-mediated nontargeted effects. Antioxid Redox Signal. 2016;25(8):467–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Panosa C, Fonge H, Ferrer-Batallé M, Menéndez JA, Massaguer A, De Llorens R, Reilly RM. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice. Nucl Med Bio. 2015;42(12):931–8.
Article
CAS
Google Scholar
Panyutin IG, Neumann RD. Radioprobing of DNA: distribution of DNA breaks produced by decay of 125I incorporated into a triplex-forming oligonucleotide correlates with geometry of the triplex. Nucleic Acids Res. 1997;25(4):883–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pedraza-López M, Ferro-Flores G, Mendiola-Cruz MT, Morales-Ramirez P. Assessment of radiation-induced DNA damage caused by the incorporation of 99mTc-radiopharmaceuticals in murine lymphocytes using single cell gel electrophoresis. Mutat Res Genet Toxicol Environ Mutagen. 2000;465(1–2):139–44.
Article
Google Scholar
Piron B, Paillas S, Boudousq V, Pèlegrin A, Bascoul-Mollevi C, Chouin N, Navarro-Teulon I, Pouget JP. DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy. Nucl Med Bio. 2014;41:e75–83.
Article
CAS
Google Scholar
Pouget JP, Georgakilas AG, Ravanat JL. Targeted and off-target (bystander and abscopal) effects of radiation therapy: redox mechanisms and risk/benefit analysis. Antioxid Redox Signal. 2018;29(15):1447–87.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pouget JP, Santoro L, Raymond L, Chouin N, Bardiès M, Bascoul-Mollevi C, Huguet H, Azria D, Kotzki PO, Pèlegrin M, Vivès E. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons. Radiat Res. 2008;170(2):192–200.
Article
CAS
PubMed
Google Scholar
Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol. 2004;22(15):3061–9.
Article
CAS
PubMed
Google Scholar
Rao D, Howell R, Narra V, Govelitz G, Sastry KR. In-vivo radiotoxicity of DNA-incorporated 125I compared with that of densely ionising alpha-particles. Lancet. 1989;334(8664):650–3.
Article
Google Scholar
Rao DV, Narra VR, Howell RW, Sastry KS. Biological consequence of nuclear versus cytoplasmic decays of125 I: Cysteamine as a radioprotector against auger cascades in vivo. Radiat Res. 1990;124(2):188–93.
Article
CAS
PubMed
Google Scholar
Razumienko EJ, Chen JC, Cai Z, Chan C, Reilly RM. Dual-receptor–targeted radioimmunotherapy of human breast cancer xenografts in athymic mice coexpressing HER2 and EGFR using 177Lu-or 111In-labeled bispecific radioimmunoconjugates. J Nucl Med. 2016;57(3):444–52.
Article
CAS
PubMed
Google Scholar
Razumienko EJ, Dryden L, Scollard D, Reilly RM. MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using 111In-labeled bispecific radioimmunoconjugates. Breast Cancer Res Treat. 2013;138(3):709–18.
Article
CAS
PubMed
Google Scholar
Rebischung C, Hoffmann D, Stefani L, Desruet MD, Wang K, Adelstein SJ, Artignan X, Vincent F, Gauchez AS, Zhang H, Fagret D. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus 125IUdR. Int J Radiat Biol. 2008;84(12):1123–9.
Article
CAS
PubMed
Google Scholar
Regulla D, Schmid E, Friedland W, Panzer W, Heinzmann U, Harder D. Enhanced values of the RBE and H ratio for cytogenetic effects induced by secondary electrons from an X-irradiated gold surface. Radiat Res. 2002;158(4):505–15.
Article
CAS
PubMed
Google Scholar
Reilly RM. The radiopharmaceutical science of monoclonal antibodies and peptides for imaging and targeted in situ radiotherapy of malignancies. In: Gad SC, editor. Handbook of pharmaceutical biotechnology. Toronto: John Wiley & Sons; 2007. p. 987–1053.
Google Scholar
Reilly RM, Kassis A. Targeted Auger electron radiotherapy of malignancies. In: Reilly RM, editor. Monoclonal antibody and peptide-targeted radiotherapy of cancer. Hoboken: John Wiley & Sons; 2010. p. 289–348.
Chapter
Google Scholar
Reilly RM, Kiarash R, Cameron RG, Porlier N, Sandhu J, Hill RP, Vallis K, Hendler A, Gariépy J. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. J Nucl Med. 2000;41(3):429–38.
CAS
PubMed
Google Scholar
Reilly RM, Scollard DA, Wang J, Mondal H, Chen P, Henderson LA, Bowen BM, Vallis KA. A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications. J Nucl Med. 2004;45(4):701–8.
CAS
PubMed
Google Scholar
Reske SN, Deisenhofer S, Glatting G, Zlatopolskiy BD, Morgenroth A, Vogg AT, Buck AK, Friesen C. 123I-ITdU–mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, β-, or γ-radiation–resistant cell lines. J Nucl Med. 2007;48(6):1000–7.
Article
CAS
PubMed
Google Scholar
Roeske JC, Aydogan B, Bardies M, Humm JL. Small-scale dosimetry: challenges and future directions. Semin Nucl Med. 2008;38:367–83.
Article
CAS
PubMed
Google Scholar
Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273(10):5858–68.
Article
CAS
PubMed
Google Scholar
Sahu SK, Wen PY, Foulon CF, Nagel JS. Intrathecal 5-(125I) Iodo-2′-deoxyuridine in a rat model of leptomeningeal metastases. J Nucl Med. 1997;38(3):386.
CAS
PubMed
Google Scholar
Salem R, Lewandowski RJ, Atassi B, Gordon SC, Gates VL, Barakat O, Sergie Z, Wong CY, Thurston KG. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol. 2005;16(12):1627–39.
Article
PubMed
Google Scholar
Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol. 1995;19(3):183–232.
Article
CAS
PubMed
Google Scholar
Santoro L, Boutaleb S, Garambois V, Bascoul-Mollevi C, Boudousq V, Kotzki PO, Pèlegrin M, Navarro-Teulon I, Pèlegrin A, Pouget JP. Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis. J Nucl Med. 2009;50(12):2033–41.
Article
PubMed
Google Scholar
Sarnelli A, Guerriero F, Botta F, Ferrari M, Strigari L, Bodei L, D'Errico V, Grassi E, Fioroni F, Paganelli G, Orecchia R. Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerations. Q J Nucl Med Mol Imaging. 2017;61(2):216–31.
Article
PubMed
Google Scholar
Schneider DO, Whitmore GF. Comparative effects of neutrons and X-rays on mammalian cells. Radiat Res. 1963;18(3):286–306.
Article
CAS
PubMed
Google Scholar
Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of 125IdU-induced DNA double-strand breaks with γ-H2AX antibody. Radiat Res. 2002;158(4):486–92.
Article
CAS
PubMed
Google Scholar
Shrivastava S, Mahantshetty U, Engineer R, Chopra S, Hawaldar R, Hande V, Kerkar RA, Maheshwari A, Shylasree TS, Ghosh J, Bajpai J. Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial. JAMA Oncol. 2018;4(4):506–13.
Article
PubMed
PubMed Central
Google Scholar
Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, Robertson JS, Howell RW, Wessels BW, Fisher DR, Weber DA. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40(2):37S–61S.
CAS
PubMed
Google Scholar
Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3(1):81–5.
CAS
PubMed
Google Scholar
Slastnikova TA, Koumarianou E, Rosenkranz AA, Vaidyanathan G, Lupanova TN, Sobolev AS, Zalutsky MR. Modular nanotransporters: a versatile approach for enhancing nuclear delivery and cytotoxicity of Auger electron-emitting 125I. EJNMMI Res. 2012;2(1):59.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sobolev AS. Modular nanotransporters for nuclear-targeted delivery of auger electron emitters. Front Pharmacol. 2018;9.
Song L, Able S, Johnson E, Vallis KA. Accumulation of 111In-labelled EGF-au-PEG nanoparticles in EGFR-positive tumours is enhanced by coadministration of targeting ligand. Nanotheranostics. 2017;1(3):232–43.
Article
PubMed
PubMed Central
Google Scholar
Song L, Falzone N, Vallis KA. EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer. Int J Radiat Biol. 2016;92(11):716–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stabin M. Nuclear medicine dosimetry. Phys Med Biol. 2006;51(13):R187–202.
Article
CAS
PubMed
Google Scholar
Stabin MG, Siegel JA. RADAR dose estimate report: a compendium of radiopharmaceutical dose estimates based on OLINDA/EXM version 2.0. J Nucl Med. 2018;59(1):154–60.
Article
PubMed
Google Scholar
Stabin MG, Siegel JA, Sparks RB, Eckerman KF, Breitz HB. Contribution to red marrow absorbed dose from total body activity: a correction to the MIRD method. J Nucl Med. 2001;42(3):492–8.
CAS
PubMed
Google Scholar
Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46(6):1023–7.
PubMed
Google Scholar
Strigari L, Konijnenberg M, Chiesa C, Bardies M, Du Y, Gleisner KS, Lassmann M, Flux G. The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy. Eur J Nucl Med Mol Imaging. 2014;41(10):1976–88.
Article
CAS
PubMed
Google Scholar
Tajik-Mansoury MA, Rajabi H, Mozdarani H. A comparison between track-structure, condensed-history Monte Carlo simulations and MIRD cellular S-values. Phys Med Biol. 2017;62(5):N90–N106.
Article
CAS
PubMed
Google Scholar
Thierens HM, Monsieurs MA, Brans B, Van Driessche T, Christiaens I, Dierckx RA. Dosimetry from organ to cellular dimensions. Comput Med Imaging Graph. 2001;25(2):187–93.
Article
CAS
PubMed
Google Scholar
Urashima T, Nagasawa H, Wang K, Adelstein SJ, Little JB, Kassis AI. Induction of apoptosis in human tumor cells after exposure to Auger electrons: comparison with γ-ray exposure. Nucl Med Biol. 2006;33(8):1055–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Uusijärvi H, Bernhardt P, Rösch F, Maecke HR, Forssell-Aronsson E. Electron-and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production. J Nucl Med. 2006;47(5):807–14.
PubMed
Google Scholar
Valkema R, De Jong M, Bakker WH, Breeman WA, Kooij PP, Lugtenburg PJ, De Jong FH, Christiansen A, Kam BL, De Herder WW, Stridsberg M. Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0] octreotide: the Rotterdam experience. Semin Nucl Med. 2002;32:110.
Article
PubMed
Google Scholar
Vallabhajosula S, Goldsmith SJ, Hamacher KA, Kostakoglu L, Konishi S, Milowski MI, Nanus DM, Bander NH. Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y-and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigen. J Nucl Med. 2005;46(5):850–8.
CAS
PubMed
Google Scholar
Vallis KA, Reilly RM, Scollard D, Merante P, Brade A, Velauthapillai S, Caldwell C, Chan I, Freeman M, Lockwood G, Miller NA. Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of 111In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer. Am J Nucl Med Mol Imaging. 2014;4(2):181–92.
CAS
PubMed
PubMed Central
Google Scholar
Vaziri B, Wu H, Dhawan AP, Du P, Howell RW, Bolch WE, Brill AB, Dewaraja YK, Dunphy MP, Fisher DR, Meredith RF. MIRD pamphlet no. 25: MIRDcell V2. 0 software tool for dosimetric analysis of biologic response of multicellular populations. J Nucl Med. 2014;55(9):1557–64.
Article
PubMed
Google Scholar
Wang YN, Hung MC. Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family. Cell Biosci. 2012;2(1):13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wilson CT. Investigations on X-rays and α-rays by the cloud method. Nature. 1923;112:26–7.
Article
Google Scholar
Woo DV, Li D, Mattis JA, Steplewski Z. Selective chromosomal damage and cytotoxicity of 125I-labeled monoclonal antibody 17-1a in human cancer cells. Cancer Res. 1989;49(11):2952–8.
CAS
PubMed
Google Scholar
Xue LY, Butler NJ, Makrigiorgos GM, Adelstein SJ, Kassis AI. Bystander effect produced by radiolabeled tumor cells in vivo. Proc Natl Acad Sci U S A. 2002;99(21):13765–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yasui LS, Chen K, Wang K, Jones TP, Caldwell J, Guse D, Kassis AI. Using Hoechst 33342 to target radioactivity to the cell nucleus. Radiat Res. 2007;167(2):167–75.
Article
CAS
PubMed
Google Scholar
Yasui LS, Hughes A, DeSombre ER. Relative biological effectiveness of accumulated 125IdU and 125I-estrogen decays in estrogen receptor-expressing MCF-7 human breast cancer cells. Radiat Res. 2001;155(2):328–34.
Article
CAS
PubMed
Google Scholar
Zatloukal P, Petruzelka L, Zemanova M, Havel L, Janku F, Judas L, Kubik A, Krepela E, Fiala P, Pecen L. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer. 2004;46(1):87–98.
Article
PubMed
Google Scholar
Zereshkian A, Leyton JV, Cai Z, Bergstrom D, Weinfeld M, Reilly RM. The human polynucleotide kinase/phosphatase (hPNKP) inhibitor A12B4C3 radiosensitizes human myeloid leukemia cells to Auger electron-emitting anti-CD123 111In-NLS-7G3 radioimmunoconjugates. Nucl Med Biol. 2014;41(5):377–83.
Article
CAS
PubMed
Google Scholar